In vivo gene expression profile analysis of human breast cancer progression.
暂无分享,去创建一个
J. Hudson | D. Sgroi | A. Elkahloun | A G Elkahloun | S. Teng | G. Robinson | R. LeVangie | D C Sgroi | S Teng | G Robinson | R LeVangie | J R Hudson | Sarena Teng | Rebbecca LeVangie
[1] S. Nelson,et al. Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridization. , 1998, Nucleic acids research.
[2] L. Liotta,et al. Laser capture microdissection. , 2006, Methods in molecular biology.
[3] Michael R. Green,et al. Dissecting the Regulatory Circuitry of a Eukaryotic Genome , 1998, Cell.
[4] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[5] A. Novelli,et al. EVIDENCE FOR FUNCTIONAL β-ADRENOCEPTOR SUBTYPES IN CG-5 BREAST CANCER CELLS , 1996 .
[6] T. Schall,et al. Physiological secretion of chemokines in human breast milk. , 1998, European cytokine network.
[7] B. Karlan,et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas , 1999, Nature Genetics.
[8] S. Gelmini,et al. Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification. , 1997, Clinical chemistry.
[9] H. Chiba,et al. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. , 1994, Nucleic acids research.
[10] G. Hair,et al. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease , 1996, Nature Medicine.
[11] Andrius Kazlauskas,et al. Diverse Signaling Pathways Activated by Growth Factor Receptors Induce Broadly Overlapping, Rather Than Independent, Sets of Genes , 1999, Cell.
[12] K. Livak,et al. Real time quantitative PCR. , 1996, Genome research.
[13] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[14] C. López-Otín,et al. Expression and prognostic significance of apolipoprotein D in breast cancer. , 1994, The American journal of pathology.
[15] P. Brown,et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] A. Olsen,et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene , 1995, Nature Genetics.
[17] D. Botstein,et al. The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.
[18] S. Linder,et al. Activation of tissue‐factor gene expression in breast carcinoma cells by stimulation of the RAF‐ERK signaling pathway , 1998, Molecular carcinogenesis.
[19] M. Cleary,et al. The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M , 1996, Molecular and cellular biology.
[20] Robert F. Bonner,et al. Laser Capture Microdissection: Molecular Analysis of Tissue , 1997, Science.
[21] M. Jackson,et al. Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.
[22] G. Shyamala,et al. Estrogen dependent expression of heat shock transcription factor: Implications for uterine synthesis of heat shock proteins , 1995, The Journal of Steroid Biochemistry and Molecular Biology.
[23] R. Rees,et al. Chemokines induce migrational responses in human breast carcinoma cell lines , 1997, International journal of cancer.